Premium
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia
Author(s) -
Giona Fiorina,
Malaspina Francesco,
Putti Maria Caterina,
Ladogana Saverio,
Mura Rosamaria,
Burnelli Roberta,
Vacca Nadia,
Rizzo Lorenzo,
Bianchi Simona,
Moleti Maria Luisa,
Testi Anna Maria,
Biondi Andrea,
Locatelli Franco,
Saglio Giuseppe,
Foà Robin
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16388
Subject(s) - medicine , dasatinib , nilotinib , imatinib mesylate , population , tyrosine kinase inhibitor , chronic myeloid leukaemia , imatinib , drug holiday , pediatrics , oncology , myeloid leukemia , immunology , cancer , environmental health , human immunodeficiency virus (hiv)